Advertisement
UK markets close in 1 hour 47 minutes
  • FTSE 100

    8,124.89
    +46.03 (+0.57%)
     
  • FTSE 250

    19,788.83
    +186.85 (+0.95%)
     
  • AIM

    755.31
    +2.19 (+0.29%)
     
  • GBP/EUR

    1.1675
    +0.0018 (+0.16%)
     
  • GBP/USD

    1.2505
    -0.0006 (-0.05%)
     
  • Bitcoin GBP

    51,189.53
    +578.62 (+1.14%)
     
  • CMC Crypto 200

    1,378.37
    -18.17 (-1.30%)
     
  • S&P 500

    5,084.22
    +35.80 (+0.71%)
     
  • DOW

    38,178.99
    +93.19 (+0.24%)
     
  • CRUDE OIL

    84.13
    +0.56 (+0.67%)
     
  • GOLD FUTURES

    2,354.30
    +11.80 (+0.50%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,082.61
    +165.33 (+0.92%)
     
  • CAC 40

    8,065.50
    +48.85 (+0.61%)
     

Drugmakers Are Planning to Start a Phase 2 Trial to Cure Peanut Allergy

Drugmakers Are Planning to Start a Phase 2 Trial to Cure Peanut Allergy

Aimmune Therapeutics Inc. is teaming with Regeneron Pharmaceuticals Inc. in hopes of developing a cure for peanut allergies.